Applied Clinical Trials-08-01-2022

How the digital environment can transform drug development space.

How these tools can help expand capacity while maintaining compliance.

Advancing risk-based auditing one step further by identifying the underlying process deficiencies to enable improved corrective and preventive actions.

Lindsay Hughes, PhD, principal scientific advisor of Clario discusses the current eCOA environment, new technology applications, and how technology implementations should be supported by science.

A look into the evolving Applied Clinical Trials podcast.

Click the title above for a link to open the Applied Clinical Trials July/August 2022 issue in an interactive PDF format.

The scope of RWE’s use in developing and approving new medicines is pitting key healthcare stakeholders against each other.

With debate swirling around products cleared through this pathway, reforms and tighter oversight likely.

Moving past the ‘if’ to the ‘how.’

Series Part 2—The process of defining QTLs.

Study evaluates the use of AI-supported medical coding module.

Presenting how data transformation is measured as part of the SAFE Data Standard, which data variables influence the rating and, how the appropriate level of data transformation is calculated.